Preparation process of non-PVC-soft-bag-packaged hemofiltration replacement liquid and product

A technology of hemofiltration and preparation technology, applied in the field of medicine, can solve the problems that the basic formula of hemofiltration replacement fluid cannot meet clinical requirements, cannot meet market demand, and has no double valve design, so as to prevent secondary pollution and shorten the detection cycle. Short, easy to adjust the effect of the prescription

Active Publication Date: 2012-07-04
HUAREN PHARMACEUTICAL CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there are a few companies in the market that can produce hemofiltration replacement fluid products, clinically, patients have different specific conditions, and when receiving hemofiltration treatment, they have different requirements for different nutrients or ion elements. The basic formula of the filtration replacement fluid cannot meet the clinical requirements, requiring medical staff to add many other ingredients to the basic hemofiltration replacement fluid formula in the later stage
However, the traditional hemofiltration replacement fluid products do not have a double valve design, no special dosing port, and the filling space is small, which cannot meet the market demand

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation process of non-PVC-soft-bag-packaged hemofiltration replacement liquid and product

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0035] The embodiment of the preparation process of a kind of non-PVC soft bag packing hemofiltration replacement fluid of the present invention:

[0036] A. The ratio of raw materials by weight is:

[0037] Sodium chloride (NaCl) 0.5-6.0g

[0038] Calcium Chloride (CaCl 2 2H 2 O) 0-0.50g

[0039] Magnesium Chloride (MgCl 2 ·6H 2 O) 0.05-0.20g

[0040] Potassium chloride (KCl) 0-0.40g

[0041] Sodium Lactate (C 3 h 5 NaO 3 ) 0-5.0g

[0042] Sodium bicarbonate (NaHCO 3 ) 0-5.0g

[0043] Glucose (C 6 h 12 o 6 ·H 2 O) 0.5-2.0g

[0044] Appropriate amount of water for injection

[0045] Full volume 1000ml

[0046] B. Preparation process

[0047] a. Preparation of liquid medicine: add at least 60% of the prescribed amount of water for injection into the concentrated preparation tank, then add at least 102.0% of the prescribed amount of anhydrous glucose, calcium chloride, magnesium chloride, at least 104.0% of the prescribed amount of sodium lactate solution and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a preparation process of non-PVC-soft-bag-packaged hemofiltration replacement liquid and a product. The preparation process is characterized by comprising the following steps: a. preparing medicine liquid: adding water for injection into a tank for high-concentration preparation, and then adding anhydrous glucose, and stirring to be dissolved; then adding 0.05% (W / V) of activated carbon, and holding at a temperature of 40 DEG C-70 DEG C, stirring and de-carbonizing for 30 minutes; removing carbon through titanium rod filtration, taking clear liquid to be put in a tankfor dilution preparation, and adding the water for injection to the full amount, and evenly stirring; b. filling: filtering through a filter, bag-making and filling in a non-PVC soft plastic infusionbag with a double-pipe and double-valve structure, adding a stopper and sealing, wherein the reserving space of the soft infusion bag is 15% or above 200ml; c. sterilizing; and d. packaging. Enough liquid adding space is reserved, the double-pipe and double-valve structure can facilitate to add liquid so as to prevent the secondary pollution and facilitate the clinical flexible adjustment of prescriptions; and the non-PVC soft infusion bag does not contain plasticizers, adhesives and other substances harmful to the human body, and does not introduce new harmful substances.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a preparation process and product of hemofiltration replacement fluid packaged in a non-PVC soft bag. Background technique [0002] Hemofiltration replacement fluid is a special replacement drug for hemofiltration, hemodiafiltration and continuous blood purification treatment. The patient uses a large amount each time, generally about 2000ml to 4000ml each time. At present, there are very few types of filtration replacement drugs used in clinical blood purification technology, and most hospitals basically prepare them manually by nurses. It takes more than half an hour for a nurse to prepare a bag of replacement fluid, but a bag of replacement fluid only takes It can be used by patients for an hour, but there are still problems such as inaccurate measurement and high risk of contamination. With the increasingly strict drug management in the country, hospital preparations need t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K33/14A61P7/08A61K33/00A61K33/06A61K31/19A61K31/7004
Inventor 初晓君吴强马丕华由明英张润荣
Owner HUAREN PHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products